Search

‘Flourishing Under Fire’ Event Highlights Professional Development and Skilling for Black Men

Flourishing Under Fire

Forum Will Explore Opportunity Growth at the Community, Corporate, and C-suite Levels; Speakers Will Include Black Leaders and Randstad Executives At a time when businesses and leaders are increasingly focused on promoting racial equity and diversity and inclusion, Randstad will bring together company executives and Black business leaders for its first ever “Flourishing Under Fire: The Future of Black Men”…

Read More

FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer

non-small cell lung cancer

The U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations. The FDA also approved the Guardant360 CDx (Guardant Health Inc.) as a companion diagnostic for Rybrevant today. “Advances in precision oncology continue…

Read More